UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.148

Sortiert nach

1‐(3‐Chlorobenzyl)pyrimidine‐2,4(1H,3H)‐dione

Acta crystallographica. Section E, Structure reports online, 2005-12, Vol.61 (12), p.o4220-o4221

2005

Volltextzugriff (PDF)

A 1.3 cm line survey toward IRC +10216

Astronomy and astrophysics (Berlin), 2015-02, Vol.574, p.A56

2015

Volltextzugriff (PDF)

A 1.3 cm line survey toward Orion KL

Astronomy and astrophysics (Berlin), 2015-09, Vol.581, p.1-60

2015

Volltextzugriff (PDF)

1018O Phase I study of GCC CAR-T therapy IM96 in patients with advanced colorectal cancer

Annals of oncology, 2023-10, Vol.34, p.S620-S620

2023

Volltextzugriff (PDF)

1124P Phase Ib study to evaluate the safety of selinexor (SEL) in combination with pembrolizumab (PEM) in patients with advanced malignancies- the: The melanoma experience

Annals of oncology, 2020-09, Vol.31, p.S756-S756

2020

Volltextzugriff (PDF)

1125P Real-world molecular testing and treatment patterns in epidermal growth factor receptor (EGFR) mutation-positive, locally advanced or metastatic Chinese non-small cell lung cancer patients failing first-line EGFR-tyrosine kinase inhibitors

Annals of oncology, 2022-09, Vol.33, p.S1066

2022

Volltextzugriff (PDF)

1207P Neurotrophin tyrosine receptor kinase (NTRK) partners identified by next-generation sequencing in Chinese patients with solid tumours

Annals of oncology, 2020-09, Vol.31, p.S791-S791

2020

Volltextzugriff (PDF)

1227P Stereotactic body radiotherapy to the lung primary lesion improves the survival of patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: A real-world study

Annals of oncology, 2021-09, Vol.32, p.S973-S973

2021

Volltextzugriff (PDF)

126 CHROMOSOME 9P21 LOCUS AND ANGIOGRAPHIC CORONARY ARTERY DISEASE BURDEN: A COLLABORATIVE META-ANALYSIS

Heart (British Cardiac Society), 2013-05, Vol.99 (suppl 2), p.A75-A75

2013

Volltextzugriff (PDF)

1319P Interdependence of KRAS and TP53 mutations in predicting benefit from immune checkpoint inhibitor (ICI) in non-squamous NSCLC

Annals of oncology, 2020-09, Vol.31, p.S852-S852

2020

Volltextzugriff (PDF)

133PA nomogram for predicting the malignant diagnosis of BI-RADS US category 4A lesions in women with dense breast tissue

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

1341P Real-world molecular testing, treatment patterns and clinical outcomes in Chinese advanced NSCLC patients, who have progressed on first-line EGFR-TKI therapy (PISCES)

Annals of oncology, 2023-10, Vol.34, p.S773-S773

2023

Volltextzugriff (PDF)

135P c-Ros oncogene 1 receptor tyrosine kinase (ROS1) partners identified by next-generation sequencing in Chinese patients with solid tumours

Annals of oncology, 2020-09, Vol.31, p.S293-S294

2020

Volltextzugriff (PDF)

137P Phase I dose-finding study of a novel anti-CTLA-4 antibody ADG116 as monotherapy in patients with advanced solid tumors

Annals of oncology, 2021-12, Vol.32, p.S1436-S1437

2021

Volltextzugriff (PDF)

139P Rearranged during transfection (RET) partners identified by next-generation sequencing in Chinese patients with solid tumours

Annals of oncology, 2020-09, Vol.31, p.S295-S295

2020

Volltextzugriff (PDF)

1439P Brain radiotherapy combined with camrelizumab and platinum-based chemotherapy as first-line treatment for advanced NSCLC with brain metastases: A multicenter, open-label, single-arm, phase II study

Annals of oncology, 2023-10, Vol.34, p.S818-S818

2023

Volltextzugriff (PDF)

1479O - Integrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

Annals of oncology, 2019-10, Vol.30, p.v602-v603

2019

Volltextzugriff (PDF)

1479OIntegrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1540P Tislelizumab combined with neoadjuvant chemoradiotherapy for resectable locally advanced oesophageal squamous cell carcinoma: A prospective, phase II clinical study

Annals of oncology, 2023-10, Vol.34, p.S865-S865

2023

Volltextzugriff (PDF)

164PPD-L1 expression affect the efficacy of pemetrexed maintenance therapy in real-world patients with advanced non-squamous NSCLC

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

194MO Phase II study of low-dose radiation (LDRT) plus durvalumab (D) and etoposide/platinum (EP) as first-line treatment in ES-SCLC (LEAD): Efficacy and safety results

ESMO open, 2024-03, Vol.9, p.102767, Article 102767

2024

Volltextzugriff (PDF)

197P Combining stereotactic body radiation and low-dose radiation (EclipseRT) with PD-1 inhibitor in mice models and patients with bulky tumor

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S147-S148

2023

Volltextzugriff (PDF)

1987P Discordant genomic correlates of PD-L1 expression in lung adenocarcinoma among multiple cohorts using dissimilar PD-L1 testing techniques

Annals of oncology, 2020-09, Vol.31, p.S1113-S1113

2020

Volltextzugriff (PDF)

2‐(2,4‐Dihydroxybenzoyl)benzoic acid

Acta crystallographica. Section E, Structure reports online, 2005-06, Vol.61 (6), p.o1769-o1770

2005

Volltextzugriff (PDF)

2,6‐Di‐tert‐butyl‐4‐(isopropylaminomethyl)phenol

Acta crystallographica. Section E, Structure reports online, 2005-12, Vol.61 (12), p.o4192-o4194

2005

Volltextzugriff (PDF)

1 – 25 von 3.148

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.961)
Mit Volltextzugriff
(2.993)

Publikationsform

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.142)
Life Sciences & Biomedicine
(1.360)
Humans
(772)
Physical Sciences
(602)
Animals
(455)
Female
(400)
Male
(388)
Physics
(364)
Biological And Medical Sciences
(266)
Technology
(255)
Mice
(230)
Science & Technology - Other Topics
(219)
Middle Aged
(215)
Oncology
(202)
Biochemistry & Molecular Biology
(199)
Adult
(187)
Astronomy & Astrophysics
(184)
Medical Sciences
(184)
Multidisciplinary Sciences
(175)
Aged
(159)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(7)
... seit 90 Tagen
(31)

Menü

Weitere Dienste

Einstellungen

1‐(3‐Chlorobenzyl)pyrimidine‐2,4(1H,3H)‐dione

A 1.3 cm line survey toward IRC +10216

A 1.3 cm line survey toward Orion KL

1018O Phase I study of GCC CAR-T therapy IM96 in patients with advanced colorectal cancer

1124P Phase Ib study to evaluate the safety of selinexor (SEL) in combination with pembrolizumab (PEM) in patients with advanced malignancies- the: The melanoma experience

1125P Real-world molecular testing and treatment patterns in epidermal growth factor receptor (EGFR) mutation-positive, locally advanced or metastatic Chinese non-small cell lung cancer patients failing first-line EGFR-tyrosine kinase inhibitors

1207P Neurotrophin tyrosine receptor kinase (NTRK) partners identified by next-generation sequencing in Chinese patients with solid tumours

1227P Stereotactic body radiotherapy to the lung primary lesion improves the survival of patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: A real-world study

126 CHROMOSOME 9P21 LOCUS AND ANGIOGRAPHIC CORONARY ARTERY DISEASE BURDEN: A COLLABORATIVE META-ANALYSIS

1319P Interdependence of KRAS and TP53 mutations in predicting benefit from immune checkpoint inhibitor (ICI) in non-squamous NSCLC

133PA nomogram for predicting the malignant diagnosis of BI-RADS US category 4A lesions in women with dense breast tissue

1341P Real-world molecular testing, treatment patterns and clinical outcomes in Chinese advanced NSCLC patients, who have progressed on first-line EGFR-TKI therapy (PISCES)

135P c-Ros oncogene 1 receptor tyrosine kinase (ROS1) partners identified by next-generation sequencing in Chinese patients with solid tumours

137P Phase I dose-finding study of a novel anti-CTLA-4 antibody ADG116 as monotherapy in patients with advanced solid tumors

139P Rearranged during transfection (RET) partners identified by next-generation sequencing in Chinese patients with solid tumours

1439P Brain radiotherapy combined with camrelizumab and platinum-based chemotherapy as first-line treatment for advanced NSCLC with brain metastases: A multicenter, open-label, single-arm, phase II study

1479O - Integrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

1479OIntegrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

1540P Tislelizumab combined with neoadjuvant chemoradiotherapy for resectable locally advanced oesophageal squamous cell carcinoma: A prospective, phase II clinical study

164PPD-L1 expression affect the efficacy of pemetrexed maintenance therapy in real-world patients with advanced non-squamous NSCLC

194MO Phase II study of low-dose radiation (LDRT) plus durvalumab (D) and etoposide/platinum (EP) as first-line treatment in ES-SCLC (LEAD): Efficacy and safety results

197P Combining stereotactic body radiation and low-dose radiation (EclipseRT) with PD-1 inhibitor in mice models and patients with bulky tumor

1987P Discordant genomic correlates of PD-L1 expression in lung adenocarcinoma among multiple cohorts using dissimilar PD-L1 testing techniques

2‐(2,4‐Dihydroxybenzoyl)benzoic acid

2,6‐Di‐tert‐butyl‐4‐(isopropylaminomethyl)phenol

Aktive Filter

Suchergebnisse filtern